Chinese BCI Startup NeuroXess Hails Breakthrough in Mind Control of Smart Devices
Summary
NeuroXess has successfully implanted patients with its self-developed invasive BCI devices, allowing them to carry out 'dialogue' with and control smart devices using their minds. The technology synthesizes thoughts into Chinese in real time and converts EEG information into language and manipulation instructions. NeuroXess plans to complete clinical registration within three years and list on STAR Market or Hong Kong around 2028.
Why it matters
Mind-controlled smart device interaction in Chinese represents a significant advance in practical BCI applications. The company's goal to list publicly by 2028 demonstrates confidence in a viable commercialization pathway for invasive BCI technology.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial